← All trials
NCT06058845
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Feb 25, 2024
- Completion date
- May 30, 2024
- First posted
- Sep 28, 2023
- Last posted
- Oct 10, 2023
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Katholieke Universiteit LeuvenLead sponsor
- Katholieke Universiteit LeuvenReponsible party - principal investigator
- Katholieke Universiteit LeuvenStudy director
- Katholieke Universiteit LeuvenOfficial
- Katholieke Universiteit LeuvenSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.